Ortíz-Lobato L, González-González M, López-Salmerón A, Reyes-Hernández CG

Language: Spanish
References: 18
Page: 53-56
PDF size: 368.71 Kb.

ABSTRACT

Eccrine porocarcinoma or malignant eccrine poroma is a rare neoplasm that originates from the eccrine sweat glands, which has a high metastatic potential; it mainly affects older adults. It is a neoplasm of unknown etiology, however, it has been related to pre-existing benign eccrine poromas. Its usual topography compromises the head and lower extremities, manifesting as an exophytic and erythematous neoformation. Diagnosis is made by histopathological study. Treatment is surgical removal; chemotherapy or radiotherapy is used in cases of metastasis or recurrence. This article reports the case of a 68-year-old patient with an eccrine porocarcinoma.

REFERENCES

1. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma. A case combining features of eccrine poroma and paget's dermatosis. Arch Dermatol. 1963; 88: 597-606

2. Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine Porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg. 2018; 44: 1247-1261.

3. Salih AM, Kakamad FH, Baba HO, Salih RQ, Hawbash MR, Mohammed SH et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg (Lond). 2017Jun;20:74-79.

4. Valverde K, Senger C, Ngan BY, Chan HS. Eccrine porocarcinoma in a child that evolved rapidly from an eccrine poroma. Med Pediatr Oncol. 2001; 37: 412-414.

5. Behbahani S, Malerba S, Karanfilian KM, Warren CJ, Alhatem A, Samie FH. Demographics and outcomes of eccrine porocarcinoma: results from the National Cancer Database. Br J Dermatol. 2020; 183: 161-163.

6. Arslan E, Tatar C, Aksoy A, Tutuncu N. De novo malignant eccrine poroma of the nose: a review of the midface as a location. Plast Reconstr Surg. 2004; 113: 2227-2229.

7. Robson A, Greene J, Ansari N, Kim B, Seed PT, McKee PH et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol. 2001; 25: 710-720.

8. Harms PW, Hovelson DH, Cani AK, Omata K, Haller MJ, Wang ML et al. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations. Hum Pathol. 2016; 51: 25-31.

9. Sawaya JL, Khachemoune A. Poroma: a review of eccrine, apocrine, and malignant forms. Int J Dermatol. 2014; 53: 1053-1061.

10. Gu LH, Ichiki Y, Kitajima Y. Aberrant expression of p16 and RB protein in eccrine porocarcinoma. J Cutan Pathol. 2002; 29: 473-479.

11. Le NS, Janik S, Liu DT, Grasl S, Faisal M, Pammer J et al. Eccrine porocarcinoma of the head and neck: meta-analysis of 120 cases. Head Neck. 2020; 42: 2644-2659.

12. Edamitsu T, Minagawa A, Koga H, Uhara H, Okuyama R. Eccrine porocarcinoma shares dermoscopic characteristics with eccrine poroma: a report of three cases and review of the published work. J Dermatol. 2016; 43: 332-335.

13. Gómez MZ, Medina M, Vélez V, Rodriguez P. Porocarcinoma ecrino: aspectos demográficos, clínicos, histopatológicos y terapéuticos en una serie de 7 pacientes. Actas Dermosifiliogr. 2017; 108: e27-e32.

14. Calonje E, Brenn T, Lazar A, Mckee P. Tumors of the sweat glands. In: McKee's pathology of the skin with clinical correlations. 5th ed. Edinburgh: Elsevier Saunders, 2020; pp. 1569-1570.

15. Barnhill RL, Crowson A, Magro CM. Piepkorn MW. Sweat Gland Tumors. 3th ed. Dermatopathology, 2010; pp. 738-739.

16. Belin E, Ezzedine K, Stanislas S, Lalanne N, Beylot-Barry M, Taieb A et al. Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol. 2011; 165: 985-989.

17. Delgado R, Kraus D, Coit DG, Busam KJ. Sentinel lymph node analysis in patients with sweat gland carcinoma. Cancer. 2003; 97: 2279-2284.

18. González-López MA, Vázquez-López F, Soler T, Gómez-Diéz S, Hidalgo GY, Manjón JA et al. Metastatic eccrine porocarcinoma: a 5.6-year follow-up study of a patient treated with a combined therapeutic protocol. Dermatol Surg. 2003; 29: 1227-1232.